Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa

Isaac M. Kigozi, Loren M. Dobkin, Jeffrey N. Martin, Elvin H. Geng, Winnie Muyindike, Nneka I. Emenyonu, David Bangsberg, Judith A. Hahn

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

BACKGROUND: Access to free antiretroviral therapy in sub-Saharan Africa has been steadily increasing, and the success of large-scale antiretroviral therapy programs depends on early initiation of HIV care. However, little is known about the stage at which those infected with HIV present for treatment in sub-Saharan Africa. METHODS: We conducted a cross-sectional analysis of initial visits to the Immune Suppression Syndrome Clinic of the Mbarara University Teaching Hospital, including patients who had their initial visit between February 2007 and February 2008 (N = 2311). RESULTS: The median age of the patients was 33 years (range 16-81 years), and 64% were female. More than one third (40%) were categorized as late presenters, that is, World Health Organization disease stage 3 or 4. Male gender, age 46-60 years (vs. younger), lower education level, being unemployed, living in a household with others, being unmarried, and lack of spousal HIV status disclosure were independently associated with late presentation, whereas being pregnant, having young children, and consuming alcohol in the prior year were associated with early presentation. CONCLUSIONS: Targeted public health interventions to facilitate earlier entry into HIV care are needed, as well as additional study to determine whether late presentation is due to delays in testing vs. delays in accessing care.

Original languageEnglish (US)
Pages (from-to)280-289
Number of pages10
JournalJournal of Acquired Immune Deficiency Syndromes
Volume52
Issue number2
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Africa South of the Sahara
HIV
Disclosure
Therapeutics
Teaching Hospitals
Public Health
Cross-Sectional Studies
Alcohols
Education

Keywords

  • Access
  • Antiretroviral therapy
  • Late presentation
  • Sub-Saharan Africa

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. / Kigozi, Isaac M.; Dobkin, Loren M.; Martin, Jeffrey N.; Geng, Elvin H.; Muyindike, Winnie; Emenyonu, Nneka I.; Bangsberg, David; Hahn, Judith A.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 52, No. 2, 10.2009, p. 280-289.

Research output: Contribution to journalArticle

Kigozi, Isaac M. ; Dobkin, Loren M. ; Martin, Jeffrey N. ; Geng, Elvin H. ; Muyindike, Winnie ; Emenyonu, Nneka I. ; Bangsberg, David ; Hahn, Judith A. / Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. In: Journal of Acquired Immune Deficiency Syndromes. 2009 ; Vol. 52, No. 2. pp. 280-289.
@article{0240f5072daa426aafa3381780762d72,
title = "Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa",
abstract = "BACKGROUND: Access to free antiretroviral therapy in sub-Saharan Africa has been steadily increasing, and the success of large-scale antiretroviral therapy programs depends on early initiation of HIV care. However, little is known about the stage at which those infected with HIV present for treatment in sub-Saharan Africa. METHODS: We conducted a cross-sectional analysis of initial visits to the Immune Suppression Syndrome Clinic of the Mbarara University Teaching Hospital, including patients who had their initial visit between February 2007 and February 2008 (N = 2311). RESULTS: The median age of the patients was 33 years (range 16-81 years), and 64{\%} were female. More than one third (40{\%}) were categorized as late presenters, that is, World Health Organization disease stage 3 or 4. Male gender, age 46-60 years (vs. younger), lower education level, being unemployed, living in a household with others, being unmarried, and lack of spousal HIV status disclosure were independently associated with late presentation, whereas being pregnant, having young children, and consuming alcohol in the prior year were associated with early presentation. CONCLUSIONS: Targeted public health interventions to facilitate earlier entry into HIV care are needed, as well as additional study to determine whether late presentation is due to delays in testing vs. delays in accessing care.",
keywords = "Access, Antiretroviral therapy, Late presentation, Sub-Saharan Africa",
author = "Kigozi, {Isaac M.} and Dobkin, {Loren M.} and Martin, {Jeffrey N.} and Geng, {Elvin H.} and Winnie Muyindike and Emenyonu, {Nneka I.} and David Bangsberg and Hahn, {Judith A.}",
year = "2009",
month = "10",
doi = "10.1097/QAI.0b013e3181ab6eab",
language = "English (US)",
volume = "52",
pages = "280--289",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa

AU - Kigozi, Isaac M.

AU - Dobkin, Loren M.

AU - Martin, Jeffrey N.

AU - Geng, Elvin H.

AU - Muyindike, Winnie

AU - Emenyonu, Nneka I.

AU - Bangsberg, David

AU - Hahn, Judith A.

PY - 2009/10

Y1 - 2009/10

N2 - BACKGROUND: Access to free antiretroviral therapy in sub-Saharan Africa has been steadily increasing, and the success of large-scale antiretroviral therapy programs depends on early initiation of HIV care. However, little is known about the stage at which those infected with HIV present for treatment in sub-Saharan Africa. METHODS: We conducted a cross-sectional analysis of initial visits to the Immune Suppression Syndrome Clinic of the Mbarara University Teaching Hospital, including patients who had their initial visit between February 2007 and February 2008 (N = 2311). RESULTS: The median age of the patients was 33 years (range 16-81 years), and 64% were female. More than one third (40%) were categorized as late presenters, that is, World Health Organization disease stage 3 or 4. Male gender, age 46-60 years (vs. younger), lower education level, being unemployed, living in a household with others, being unmarried, and lack of spousal HIV status disclosure were independently associated with late presentation, whereas being pregnant, having young children, and consuming alcohol in the prior year were associated with early presentation. CONCLUSIONS: Targeted public health interventions to facilitate earlier entry into HIV care are needed, as well as additional study to determine whether late presentation is due to delays in testing vs. delays in accessing care.

AB - BACKGROUND: Access to free antiretroviral therapy in sub-Saharan Africa has been steadily increasing, and the success of large-scale antiretroviral therapy programs depends on early initiation of HIV care. However, little is known about the stage at which those infected with HIV present for treatment in sub-Saharan Africa. METHODS: We conducted a cross-sectional analysis of initial visits to the Immune Suppression Syndrome Clinic of the Mbarara University Teaching Hospital, including patients who had their initial visit between February 2007 and February 2008 (N = 2311). RESULTS: The median age of the patients was 33 years (range 16-81 years), and 64% were female. More than one third (40%) were categorized as late presenters, that is, World Health Organization disease stage 3 or 4. Male gender, age 46-60 years (vs. younger), lower education level, being unemployed, living in a household with others, being unmarried, and lack of spousal HIV status disclosure were independently associated with late presentation, whereas being pregnant, having young children, and consuming alcohol in the prior year were associated with early presentation. CONCLUSIONS: Targeted public health interventions to facilitate earlier entry into HIV care are needed, as well as additional study to determine whether late presentation is due to delays in testing vs. delays in accessing care.

KW - Access

KW - Antiretroviral therapy

KW - Late presentation

KW - Sub-Saharan Africa

UR - http://www.scopus.com/inward/record.url?scp=70349690548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349690548&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3181ab6eab

DO - 10.1097/QAI.0b013e3181ab6eab

M3 - Article

C2 - 19521248

AN - SCOPUS:70349690548

VL - 52

SP - 280

EP - 289

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 2

ER -